Tenax Therapeutics Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Chris Giordano
Chief executive officer
US$522.6k
Total compensation
CEO salary percentage | 73.9% |
CEO tenure | 1.8yrs |
CEO ownership | n/a |
Management average tenure | 2yrs |
Board average tenure | 2.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2022 | n/a | n/a | -US$12m |
Jun 30 2022 | n/a | n/a | -US$13m |
Mar 31 2022 | n/a | n/a | -US$11m |
Dec 31 2021 | US$861k | US$183k | -US$32m |
Compensation vs Market: Chris's total compensation ($USD522.58K) is about average for companies of similar size in the German market ($USD417.54K).
Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.
CEO
Chris Giordano (47 yo)
1.8yrs
Tenure
US$522,582
Compensation
Mr. Christopher T. Giordano, also known as Chris, has been the Chief Executive Officer and Director of Tenax Therapeutics, Inc. since July 14, 2021 and serves as its President since October 29, 2021. He se...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 1.8yrs | US$522.58k | no data | |
Interim Chief Financial Officer | 1.5yrs | US$210.10k | no data | |
Chairman of Scientific Advisory Board | 2.3yrs | US$375.44k | 1.26% $ 43.7k | |
Executive VP of Legal Affairs | 13.5yrs | no data | no data | |
Executive Vice President of Commercial & Business Operations | no data | no data | no data | |
Senior Vice President of Regulatory Affairs | no data | no data | no data |
2.0yrs
Average Tenure
64yo
Average Age
Experienced Management: YBO's management team is considered experienced (2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 1.8yrs | US$522.58k | no data | |
Chairman of Scientific Advisory Board | 5.2yrs | US$375.44k | 1.26% $ 43.7k | |
Independent Chairman | 9yrs | US$81.11k | 0.00081% $ 28.1 | |
Independent Director | 2.2yrs | US$60.11k | 0.33% $ 11.4k | |
Member of Scientific Advisory Board | 5.2yrs | no data | no data | |
Independent Director | 2.2yrs | US$51.11k | 1.96% $ 68.1k | |
Independent Director | 1.3yrs | US$68.26k | no data | |
Independent Director | 2.2yrs | US$62.11k | 0% $ 0 | |
Member of Scientific Advisory Board | 5.2yrs | no data | no data | |
Member of Scientific Advisory Board | 3.2yrs | no data | no data | |
Member of PAH Scientific Advisory Board | no data | no data | no data | |
Member of PAH Scientific Advisory Board | no data | no data | no data |
2.7yrs
Average Tenure
65yo
Average Age
Experienced Board: YBO's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.